0.00Open0.01Pre Close0 Volume97 Open Interest100.00Strike Price0.00Turnover0.00%IV59.05%PremiumApr 4, 2025Expiry Date0.00Intrinsic Value100Multiplier-12DDays to Expiry0.01Extrinsic Value100Contract SizeAmericanOptions Type--Delta--Gamma6288.00Leverage Ratio--Theta--Rho--Eff Leverage--Vega
Novo-Nordisk A/S Stock Discussion
Novo Nordisk Share Valuation from Andersen, he sees Novo’s shares as undervalued at a 32% discount to its estimated fair value of DKK 640. W...
"Novo Nordisk’s €1 billion investment in CARDIOR PHARMACEUTICALS strongly suggests potential blockbuster territory. Especially since it involves CDR132L, a novel RNA-based therapy for heart failure, a condition tha...
Is this stock seen as a long term (2 years) stock? I've already DCA down several times and my average is still at 85. When will I get out of this
Cash and cash equivalents + Short-term investments:
Novo Nordisk has approximately DKK 26.308 billion in liquid assets (DKK 15.655 + DKK 10.653 billion). This is positive, because a healthy cash position means that the company has sufficient resources to cover operational costs and repay short-term obligations.
Interpretation:
A strong liquidity position helps to absorb unexpected expenses or temporary setbacks. The fact...
No comment yet